TipRanks
Go Ultimate55% OFF

Octave Specialty Group (FGPN) Q2 2026 Earnings Report

DE:FGPN Q2 2026 EPS Results

Actual EPS
-EUR 0.04
Consensus EPS
EUR 0.00
Beat/Miss
Missed by -EUR 0.03
One Year Ago EPS
-EUR 0.20

DE:FGPN Q2 2026 Revenue Results

Actual Revenue
EUR 74.31M
Expected Revenue
EUR 20.41M
Beat/Miss
Beat by +EUR 53.91M
YoY Revenue Growth
+51.02%

Earnings Announcement Details

Quarter
Q2 2026
Date
08/06/2026
Time
After Close
Conference Call
Thursday, August 6, 2026
DE:FGPN Upcoming Earnings

Octave Specialty Group's next earnings date is estimated for November 9, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:FGPN Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Aug 06, 2026|% Change Since:-10.39%|
Earnings Call Sentiment|Positive

The call emphasized strong and accelerating performance in the Insurance Distribution segment (77% revenue growth, 44% organic), material quarter-over-quarter improvements in consolidated and segment profitability, meaningful underwriting progress at Everspan (loss ratio and combined ratio improvements), and operational initiatives (AI, talent hires) that support scalable growth. At the same time, the company remains GAAP unprofitable, reduced its adjusted EPS and Everspan EBITDA guidance for near-term items (acquisition/onboarding costs), faces a softening P&C market in certain property classes, and is making near-term investments (MGAs, technology) that depress current margins. On balance, operational momentum and improving adjusted results outweigh the near-term headwinds and guidance adjustments.

Company Guidance

Management updated 2026 guidance, raising Insurance Distribution organic growth to 25%+ (from 20%+) and increasing Insurance Distribution adjusted EBITDA guidance to $45M (from $40M) — reflecting Q2 momentum (Insurance Distribution Q2 revenue +77%, Q2 organic growth 44%, Q2 adjusted EBITDA ≈$10M and YTD adjusted EBITDA $35M with an approx. 26% margin). Everspan’s adjusted EBITDA guidance was lowered to $6M (from $7.5M), which would still represent a ~58% increase over 2025’s $3.8M adjusted EBITDA, due to higher near-term acquisition costs. Consolidated adjusted net income per share guidance was revised to $0.15–$0.20 (vs. prior $0.50), with the midpoint implying roughly a $0.76 per-share improvement from 2025’s adjusted loss of $0.58; management reiterated 2026 is expected to be the first year of positive adjusted net income per share (ex-legacy financial guarantee business) since the P&C strategy launch.

  • Insurance Distribution Revenue and Organic GrowthInsurance Distribution revenue grew 77% year-over-year to $58.4 million in Q2 2026, driven by 44% organic growth and the October 2025 acquisition of ArmadaCare.
  • Insurance Distribution Profitability ExpansionInsurance Distribution adjusted EBITDA nearly quadrupled year-over-year to approximately $9.8–$10.0 million; margins expanded materially (CFO reported 16.8% vs 7.6% prior year, CEO noted YTD adjusted EBITDA margin expansion to ~26% from 13%).
  • Material Consolidated Earnings ImprovementConsolidated adjusted EBITDA to shareholders improved to +$3.7 million (from -$4.6 million prior), and consolidated EBITDA improved to -$1.7 million (from -$9.8 million), representing multi-million-dollar quarter-over-quarter improvements (~$8.1–$8.3 million).
  • Net Loss and Adjusted Net Loss TrendsNet loss to shareholders improved to $14.4 million ($0.33 per share) from $20.5 million ($0.42 per share) year-over-year (improvement > $6 million). Consolidated adjusted net loss to shareholders improved to -$1.8 million ($0.04 per share) from -$10.6 million ($0.22 per share), an $8.7 million improvement.
  • Everspan Underwriting ProgressEverspan showed improving underwriting performance: gross premiums $95M, net $23M, earned $22M (gross -2% YoY; net +52%; earned +34%); reported loss ratio improved 640 basis points to 61.4% (active programs ~59%); combined ratio declined to 100.6% from 106.7%; pretax income $1.2M and adjusted EBITDA $1.8M (double/near-triple prior year).
  • Guidance Raised for Insurance DistributionManagement raised Insurance Distribution guidance: now expects organic growth of 25%+ (up from 20%+) and increased adjusted EBITDA guidance for the segment to $45 million (from $40 million).
  • Cost Discipline and Corporate Expense ReductionReported GAAP corporate expenses declined 14% year-over-year to $12 million (from $14 million); adjusted corporate expenses declined to $7.9 million from $8.3 million, reflecting ongoing expense containment.
  • AI and Underwriting Automation GainsLaunched proprietary AI-driven underwriting platform in collaboration with Cytora across select U.S. MGAs; submit-to-quote time reduced from several hours to ~7 minutes in examples, improving speed and underwriting efficiency and expected to be rolled out across remaining applicable U.S. MGAs in H2 2026.
  • A&H Market Strength and Product DiversificationA&H lines (including ArmadaCare) continue to show constructive trends and secular growth, with positive rate environments in many A&H sectors (low double-digit / high single-digit), and the broader diversified portfolio reduces single-product-cycle exposure.
  • MGA Portfolio Scaling MomentumClass of 2024 and 2025 MGAs drove ~75% of organic growth this quarter; roughly half of that class are already delivering EBITDA, and management expects continued scaling and material EBITDA expansion through 2028.

DE:FGPN Earnings History

DE:FGPN earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Nov 09, 20262026 (Q3)-0.04--0.19――
Aug 06, 20262026 (Q2)-0.00-0.04-0.281.82% (+0.16)
May 06, 20262026 (Q1)0.030.33-0.12384.62% (+0.45)
Feb 23, 20262025 (Q4)-0.13-0.02-0.1183.33% (+0.09)
Nov 10, 20252025 (Q3)-0.18-0.19-0.4154.35% (+0.22)
Aug 07, 20252025 (Q2)-0.17-0.200.16-222.22% (-0.36)
May 12, 20252025 (Q1)-0.06-0.120.73-115.85% (-0.85)
Feb 26, 20252024 (Q4)0.00-0.110.29-137.50% (-0.39)
Nov 12, 20242024 (Q3)0.07-0.411.79-123.00% (-2.20)
Aug 05, 20242024 (Q2)0.130.160.06157.14% (+0.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More